Childhood Obesity; a Randomized Controlled Study of Group Treatment Targeting Parents Behaviour
Childhood Obesity: a Study of Group Treatment Targeting Parents Behaviour
Sponsors
Source
Norwegian University of Science and Technology
Oversight Info
Has Dmc
No
Brief Summary
Long term effects of treatment of childhood obesity are not well documented but there is
growing evidence that parental involvement and behavioral changes are strong predictors of
children weight loss. However, which form and content of parental involvement are most
effective is not studied. In the present randomized controlled study we compare the effect of
parent manualized group treatment ("experimental group") to the effect of parent self-help
groups on changes in children Body Mass Index, food intake, physical activity, quality of
life and self esteem. We pose the following hypotheses:
1. Parents participating in the experimental group will have children who achieve a larger
reduction in BMI than children with their parents in the control group.
2. This treatment effect will be mediated by changes in one of several elements of parents'
cognition: outcome expectancies, perceived control, perceived value of outcome,
self-efficacy, perceived reduction in barriers, and subjective norms.
3. Reduction in BMI will correlate with increased quality of life, reduced number and
severity of mental health problems, and increased self-concept.
Detailed Description
The prevalence of obesity as increased dramatically in substantial parts of the world during
the last decade, a weight increase also seen in children. This epidemic has also reached
Norway, with a worrying increase in the prevalence of overweight and obese school aged
children. Reports from US studies show a substantial increase in diabetes II among overweight
children. Such an increase is currently not detected among Norwegian children. However, if
the increase in childhood obesity continues or worsens, we should expect the onset of weight
related disorders such as Diabetes II and Cardio-vascular to take place earlier in life. In
addition, there would be an expected increase in psychosocial problems (poor self-concept,
social isolation) and psychiatric symptoms and disorders associated with obesity (e.g. eating
problems and depression). Hence, both preventive and treatment efforts are called for.
Parents need to be included The treatment of obesity among children has traditionally
addressed the child by means of diet and exercise, often involving in-patient treatment.
Slowly, the evidence concerning the importance of including the parents in the treatment have
emerged as well as the need for addressing the child's wider social context. Hence, childhood
obesity should first and foremost be conceived of as a behavioral problem. Generally,
behaviorally oriented approaches have emerged as the most successful. Such behavioral
procedures have been conducted within a framework of individual consultations to each
child/family. It was reported that after family oriented behavioral treatment 30 % of the
previously overweight children no longer qualified for overweight, whereas 34 % had sustained
minimum 20 % reduction in their overweight. The best predictors of the long term course of
overweight reduction were the family eating and exercise environment, in addition to support
from friends and family. Notably, the intervention group targeting both children and parents
fared best. Such a finding concurs with the conclusion that family and parent based
approaches are associated with weight loss among obese children.
Less is known concerning the specifics of effective parental involvement, that is which form
of parental involvement are most effective and the content of effective interventions.
Therapies targeting individual families are costly to undertake and time consuming for the
family. We therefore need to balance the benefits of family treatment with their costs,
aiming at an optimal intervention level that provides the best therapeutic results with the
lowest degree of investments. We will therefore adopt a group treatment paradigm.
Lessons should be learned from the treatment of other childhood behavioral problems.
Moreover, interventions within pediatric obesity has to a surprisingly little extent drawn
upon the mounting knowledge from successful interventions regarding other types of childhood
behavioral problems, e.g. conduct problems. Such interventions generally try to strengthen
general parenting practices (e.g. limit setting, consistency, anger management, affective
availability) in order to increase the parents' competencies in regulating the child's
problem behavior. The behavioral techniques that traditional obesity intervention programs
try to get parents to adapt at home (e.g. getting their children to exercise more or eat
smaller portions) seem to require some basic parenting skills. When parents fall short of
actually doing what they have learned, it may be due to the fact that regarding eating and
physical activity, the behavior of obese children are especially demanding and putting
parenting skills to the test. Hence, specific training of skills that increase the likelihood
of behavioral change in the parent and in the child should be included in intervention
programs. In doing so, manualized treatment should be encouraged in order to facilitate
replications and clinical use, but is often left wanting. Although some exception do exist,
many studies only include short-term post-treatment outcomes only. Thus, children need to be
followed for longer time periods, due to the fact that short-term weight reduction is
achieved by numerous intervention strategies, whereas long-term weight reduction should be
the primary goal.
Lessons should be learned from general models of health behavior Within a preventive
framework several theoretical models have been devised pinpointing the cognitive and social
factors determining health promoting behaviors, also including health behaviors important for
the development of adiposity in childhood. The predictive power of such models in determining
future health behaviors is high, also when eating and physical activity in children and
adolescents are considered. Such basic knowledge has only to a very limited extent been
integrated into treatment models of obesity in childhood. We hence aim at targeting those
behaviors in parents that may facilitate health promoting behavior in their offspring.
Numerous models of health behaviors exist. Their construct overlap to some extent, but each
have some merits of their own. Our vantage point has therefore been the arguably most widely
accepted model of health behavior, namely Ajzen's Theory of Planned Behavior, and
supplementing it with the barriers towards health promoting behavior element stemming from
the "Health Belief Model" and Bandura's concept of self-efficacy (1977), viz. the person's
beliefs in her/his ability to perform the behavior in question. Figure 1 depicts our
theoretical model for the content of the parent based group intervention program. In
addition, we expect that weight reduction will imply additional positive outcomes for the
child including increased quality of life, increased self-concept and reduction in
psychiatric symptoms. However, we should expect that such characteristics of the child may
moderate the effect of the intervention.
The considerations above imply that treatment programs for childhood obesity should:
1. Aim for enduring life-style changes with respect to eating and physical activity. The
treatment should target the family members' habits and cognitions. Low intensity
interventions are the ones that are applicable in most practical contexts, and such
programs demand less extensive efforts and changes of the family's way of living, are
ones that also have the potential for success in the long run.
2. Target the children's behavior by means of involving their parents. We contend that it
is more effective to have the parents regulating their child's eating and exercising
behavior than having health personnel trying to do this directly by treating the child
on his or her own. Parents can thus regulate the stimulus conditions that govern the
child's eating and exercising behavior by reducing cues and possibilities for excessive
intake of fattening foods, and increasing cues and opportunities for physical activity
and healthy eating.
3. Strengthen general and specific parenting skills. Teaching parents about the importance
of healthy eating, meal preparation, and physical activity is not enough to achieve
enduring effects. The main challenge is not for parents not knowing what to do, but
rather actually being able to carry through the behavior in front of challenges or
barriers (e.g. being bereaved of the opportunity to having a snack themselves;
guilt-inducing behavior from the child). By addressing their own behavior and by
teaching specific skills to overcome such barriers, parents may learn new parenting
skills that alter the conditions for their child's behavior in a long-term perspective.
4. Target the parents' cognitions about the effect of their own behavior. The treatment
should address those cognitions that maintain their weight related behavior towards the
child. These cognitions are outlined in Figure 1.
5. Treat parents in groups. Group treatments are cost-effective. In addition, parents of
obese children may learn from the experience of other parents, and they may provide
emotional and social support. Finally, the social control element of reporting of
completion or failure to perform homework between sessions should not be underestimated.
However, in order to secure that the needs of each family/child are met, individual
sessions including weight control should be scheduled.
6. Focus on mastery and solutions. In order to promote treatment optimism the treatment
should address what the family actually has achieved at the expense of failures.
At present we have little knowledge about the demographics and psychosocial characteristics
of clinic-referred children with adiposity in Norway. We will provide descriptive information
about this population concerning medical conditions and nutritional status, as well as
psychological factors and potential psychiatric symptoms associated with overweight.
Moreover, we will address the issue whether successful treatment also will alleviate
psychosocial problems such as self-concept problems and increases quality of life. Finally,
we ask whether weight reduction in the child are associated with changes in the parents'
health beliefs, whether the expected changes in parental health beliefs mediate the effect of
the intervention.
Overall Status
Completed
Start Date
2004-10-01
Completion Date
2010-04-01
Primary Completion Date
2010-04-01
Phase
Phase 2
Study Type
Interventional
Primary Outcome
Measure |
Time Frame |
Body Mass Index, lean body mass, waist circumference, energy intake, physical activity, physical fitness, quality of life, self-esteem, Parental body mass index, parental eating behaviour, parental levels of physical activity. |
Baseline, 6 months and 24 months |
Enrollment
99
Condition
Intervention
Intervention Type
Behavioral
Intervention Name
Description
Parent manualized group treatment in childhood obesity; 10 manualized group treatment over a 6 months period.
Ten sessions will be conducted with the following content: 1) Expectancies and goal setting,; 2) Taking to the child about overweight; 3) Daily physical activity; 4) Everyday meals and nutrition; 5) Mastery and motivation; 6) Guidance and limit setting; 7) Who should join the team? The role of siblings and the social network; 8) Parents' history of eating and physical activity; 9) Self-concept and body image; and 10) Vacations and parties.
Thereafter booster-meetings every third month over 1,5 years, in all 2 years treatment
Arm Group Label
Parent group treatment
Intervention Type
Behavioral
Intervention Name
Description
Professionals initiate and organize the self-help groups initially and attend the two first meetings. Their role will be to organize group and facilitate group rules governing group behaviors to be formed. The sharing of experiences, feelings, and thoughts concerning being a parent to an overweight child is encouraged, in addition to sharing tips and advices concerning managing their child's behavior. The groups will not receive any teaching or counseling concerning eating and physical activity.
Arm Group Label
Parent self-help groups
Eligibility
Criteria
Inclusion Criteria:
- Age 7-12 years
- Body Mass Index > 2SDS (age adjusted BMI)
- no known medical cause of obesity
Exclusion Criteria:
- pervasive developmental disorders
- serious psychopathology
- parental drug abuse
Gender
All
Minimum Age
7 Years
Maximum Age
12 Years
Healthy Volunteers
No
Overall Official
Last Name |
Role |
Affiliation |
Ronnaug A Odegard, MD, PhD |
Principal Investigator |
St. Olavs Hospital |
Location
Facility |
St Olav University Hospital, Department of Pediatrics Trondheim. Olav Kyrres gt 17 Trondheim 7006 Norway |
Location Countries
Country
Norway
Verification Date
2016-07-01
Lastchanged Date
N/A
Firstreceived Date
N/A
Responsible Party
Responsible Party Type
Sponsor
Keywords
Has Expanded Access
No
Condition Browse
Number Of Arms
2
Arm Group
Arm Group Label
Parent group treatment
Arm Group Type
Experimental
Description
Manualized group treatment of parents. Allocation of 4-6 parental couples of children with similar age.
Arm Group Label
Parent self-help groups
Arm Group Type
Active Comparator
Description
Professionals initiate and organize the self-help groups initially. The groups will not receive any teaching or counseling concerning eating and physical activity.
Results Reference
Citation
Hystad HT, Steinsbekk S, Ødegård R, Wichstrøm L, Gudbrandsen OA. A randomised study on the effectiveness of therapist-led v. self-help parental intervention for treating childhood obesity. Br J Nutr. 2013 Sep 28;110(6):1143-50. doi: 10.1017/S0007114513000056. Epub 2013 Feb 6.
PMID
23388524
Firstreceived Results Date
N/A
Firstreceived Results Disposition Date
N/A
Study Design Info
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)
Study First Submitted
February 11, 2009
Study First Submitted Qc
February 11, 2009
Study First Posted
February 12, 2009
Last Update Submitted
July 27, 2016
Last Update Submitted Qc
July 27, 2016
Last Update Posted
July 28, 2016
ClinicalTrials.gov processed this data on December 13, 2019
Conditions
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Interventions
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Study Phase
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.